Clarus Therapeutics Holdings, Inc., along with its affiliate, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on September 5, 2022. As per the motion, the debtor seeks the joint administration of the cases of its affiliate, Clarus Therapeutics, Inc., with its own case for administrative and procedural purposes. Clarus Therapeutics Holdings, Inc. has been proposed as the lead debtor.